The Placenta Contributes to Activation of the Renin Angiotensin System in Twin-Twin Transfusion Syndrome

Placenta

Volumn 29, Issue 8, 2008, Pages 734-742

  Galea, P ^a,b   Barigye, O ^a,b   Wee, L ^a,b   Jain, V ^a,b   Sullivan, M ^a   Fisk, N M ^a,b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Monochorionic twins; Placenta; Renin angiotensin system; Twin twin transfusion syndrome

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; RENIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 3;

ANGIOTENSIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FETUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICROARRAY ANALYSIS; PLACENTA; PLASMA RENIN ACTIVITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TWIN TWIN TRANSFUSION SYNDROME; WESTERN BLOTTING;

ANGIOTENSIN II; FEMALE; FETOFETAL TRANSFUSION; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA; PREGNANCY; PREGNANCY, MULTIPLE; RENIN; RENIN-ANGIOTENSIN SYSTEM; TWINS;

EID: 49049102062     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.04.010     Document Type: Article

References (47)

1. Gardiner H.M., Taylor M.J., Karatza A., Vanderheyden T., Huber A., Greenwald S.E., et al. Twin-twin transfusion syndrome: the influence of intrauterine laser photocoagulation on arterial distensibility in childhood. Circulation 107 (2003) 1906-1911
2. Cheung Y.F., Taylor M.J., Fisk N.M., Redington A.N., and Gardiner H.M. Fetal origins of reduced arterial distensibility in the donor twin in twin-twin transfusion syndrome. Lancet 355 (2000) 1157-1158
3. Denbow M.L., Cox P., Taylor M., Hammal D.M., and Fisk N.M. Placental angioarchitecture in monochorionic twin pregnancies: relationship to fetal growth, fetofetal transfusion syndrome, and pregnancy outcome. Am J Obstet Gynecol 182 (2000) 417-426
4. Jain V., and Fisk N.M. The twin-twin transfusion syndrome. Clin Obstet Gynecol 47 (2004) 181-202
5. Mari G., Roberts A., Detti L., Kovanci E., Stefos T., Bahado-Singh R.O., et al. Perinatal morbidity and mortality rates in severe twin-twin transfusion syndrome: results of the International Amnioreduction Registry. Am J Obstet Gynecol 185 (2001) 708-715
6. Graef C., Ellenrieder B., Hecher K., Hackeloer B.J., Huber A., and Bartmann P. Long-term neurodevelopmental outcome of 167 children after intrauterine laser treatment for severe twin-twin transfusion syndrome. Am J Obstet Gynecol 194 (2006) 303-308
7. Denbow M.L., Battin M.R., Cowan F., Azzopardi D., Edwards A.D., and Fisk N.M. Neonatal cranial ultrasonographic findings in preterm twins complicated by severe fetofetal transfusion syndrome. Am J Obstet Gynecol 178 (1998) 479-483
8. Haverkamp F., Lex C., Hanisch C., Fahnenstich H., and Zerres K. Neurodevelopmental risks in twin-to-twin transfusion syndrome: preliminary findings. Eur J Paediatr Neurol 5 (2001) 21-27
9. Banek C.S., Hecher K., Hackeloer B.J., and Bartmann P. Long-term neurodevelopmental outcome after intrauterine laser treatment for severe twin-twin transfusion syndrome. Am J Obstet Gynecol 188 (2003) 876-880
10. Fisk N.M., and Galea P. Twin-twin transfusion-as good as it gets?. N Engl J Med 351 (2004) 182-184
11. Senat M.V., Deprest J., Boulvain M., Paupe A., Winer N., and Ville Y. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med 351 (2004) 136-144
12. Mahieu-Caputo D., Salomon L.J., Le Bidois J., Fermont L., Brunhes A., Jouvet P., et al. Fetal hypertension: an insight into the pathogenesis of the twin-twin transfusion syndrome. Prenat Diagn 23 (2003) 640-645
13. Zosmer N., Bajoria R., Weiner E., Rigby M., Vaughan J., and Fisk N.M. Clinical and echographic features of in utero cardiac dysfunction in the recipient twin in twin-twin transfusion syndrome. Br Heart J 72 (1994) 74-79
14. Karatza A.A., Wolfenden J.L., Taylor M.J., Wee L., Fisk N.M., and Gardiner H.M. Influence of twin-twin transfusion syndrome on fetal cardiovascular structure and function: prospective case-control study of 136 monochorionic twin pregnancies. Heart 88 (2002) 271-277
15. Taylor M.J., Shalev E., Tanawattanacharoen S., Jolly M., Kumar S., Weiner E., et al. Ultrasound-guided umbilical cord occlusion using bipolar diathermy for Stage III/IV twin-twin transfusion syndrome. Prenat Diagn 22 (2002) 70-76
16. Taylor G.M., Peart W.S., Porter K.A., Zondek L.H., and Zondek T. Concentration and molecular forms of active and inactive renin in human fetal kidney, amniotic fluid and adrenal gland: evidence for renin-angiotensin system hyperactivity in 2nd trimester of pregnancy. J Hypertens 4 (1986) 121-129
17. Mahieu-Caputo D., Muller F., Joly D., Gubler M.C., Lebidois J., Fermont L., et al. Pathogenesis of twin-twin transfusion syndrome: the renin-angiotensin system hypothesis. Fetal Diagn Ther 16 (2001) 241-244
18. Kilby M.D., Platt C., Whittle M.J., Oxley J., and Lindop G.B. Renin gene expression in fetal kidneys of pregnancies complicated by twin-twin transfusion syndrome. Pediatr Dev Pathol 4 (2001) 175-179
19. Mahieu-Caputo D., Dommergues M., Delezoide A.L., Lacoste M., Cai Y., Narcy F., et al. Twin-to-twin transfusion syndrome. Role of the fetal renin-angiotensin system. Am J Pathol 156 (2000) 629-636
20. Wee L.Y., Sullivan M.H., Humphries K.N., and Fisk N.M. Longitudinal blood flow in shared (arteriovenous anastomoses) and non-shared cotyledons in monochorionic placentae. Placenta 28 (2007) 516-522
21. Nielsen A.H., Schauser K.H., and Poulsen K. Current topic: the uteroplacental renin-angiotensin system. Placenta 21 (2000) 468-477
22. Cooper A.C., Robinson G., Vinson G.P., Cheung W.T., and Broughton Pipkin F. The localization and expression of the renin-angiotensin system in the human placenta throughout pregnancy. Placenta 20 (1999) 467-474
23. Li C., Ansari R., Yu Z., and Shah D. Definitive molecular evidence of renin-angiotensin system in human uterine decidual cells. Hypertension 36 (2000) 159-164
24. Knock G.A., Sullivan M.H., McCarthy A., Elder M.G., Polak J.M., and Wharton J. Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies. J Pharmacol Exp Ther 271 (1994) 1007-1015
25. Li X., Shams M., Zhu J., Khalig A., Wilkes M., Whittle M., et al. Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants. J Clin Invest 101 (1998) 442-454
26. Shah D.M. Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am J Physiol Renal Physiol 288 (2005) F614-F625
27. Quintero R.A., Morales W.J., Allen M.H., Bornick P.W., Johnson P.K., and Kruger M. Staging of twin-twin transfusion syndrome. J Perinatol 19 (1999) 550-555
28. Deinum J., Derkx F.H.M., and Schalekamp M.A.D.H. Improved immunoradiometric assay for plasma renin. Clin Chem 45 (1999) 847-854
29. Volland H., Pradelles P., Ronco P., Azizi M., Simon D., Creminon C., et al. A solid-phase immobilised epitope immunoassay (SPIE-IA) permitting very sensitive and specific measurement of angiotensin II in plasma. J Immunol Methods 228 (1999) 37-47
30. Bradford M.M. A rapid and sensitive method for quantification of microgram quantities of protein using the principle of protein-dye-binding. Anal Biochem 72 (1976) 248-254
31. Poisner A.M. The human placental renin-angiotensin system. Front Neuroendocrinol 19 (1998) 232-252
32. Mahieu-Caputo D., Meulemans A., Martinovic J., Gubler M.C., Delezoide A.L., Muller F., et al. Paradoxic activation of the renin-angiotensin system in twin-twin transfusion syndrome: an explanation for cardiovascular disturbances in the recipient. Pediatr Res 58 (2005) 685-688
33. Kingdom J.C., McQueen J., Connell J.M., and Whittle M.J. Fetal angiotensin II levels and vascular (type I) angiotensin receptors in pregnancies complicated by intrauterine growth retardation. Br J Obstet Gynaecol 100 (1993) 476-482
34. Wee L.Y., Sebire N.J., Bhundia J., Sullivan M., and Fisk N.M. Histomorphometric characterisation of shared and non-shared cotyledonary villus territories of monochorionic placentae in relation to pregnancy complications. Placenta 27 (2006) 475-482
35. Yagami H., Kurauchi O., Murata Y., Okamoto T., Mizutani S., and Tomoda Y. Expression of angiotensin-converting enzyme in human placenta and its physiologic role in the fetal circulation. Obstet Gynecol 84 (1994) 453-457
36. Germain S., Bonnet F., Philippe J., Fuchs S., Corvol P., and Pinet F. A novel distal enhancer confers chorionic expression on the human renin gene. J Biol Chem 273 (1998) 25292-25300
37. Downing G.J., and Poisner A.M. Stimulation of placental prorenin secretion by selective inhibition of cyclic nucleotide phosphodiesterases. Biochem Pharmacol 49 (1995) 1675-1682
38. Downing G.J., Yan B., and Poisner A.M. Beta-adrenoreceptor activation-induced placental prorenin secretion is mediated by increased renin messenger RNA and protein synthesis. Mol Pharm 51 (1997) 201-208
39. Brar H.S., Kjos S.L., Dougherty W., Do Y.S., Tam H.B., and Hsueh W.A. Increased fetoplacental active renin production in pregnancy-induced hyptertension. Am J Obstet Gynecol 157 (1987) 363-367
40. Singh H.J., Rahman A., Larmie E.T., and Nila A. Raised prorenin and renin concentrations in pre-eclamptic placentae when measured after acid activation. Placenta 25 (2004) 631-636
41. Denbow M., Fogliani R., Kyle P., Letsky E., Nicolini U., and Fisk N. Haematological indices at fetal blood sampling in monochorionic pregnancies complicated by feto-fetal transfusion syndrome. Prenat Diagn 18 (1998) 941-946
42. Poisner A.M. Regulation of utero-placental prorenin. Adv Exp Med Biol 377 (1995) 411-426
43. Poisner A.M., Thrailkill K., Poisner R., and Handwerger S. Cyclic AMP as a second messenger for prorenin release from human decidual cells. Placenta 12 (1991) 263-267
44. Bajoria R., Sullivan M., and Fisk N.M. Endothelin concentrations in monochorionic twins with severe twin-twin transfusion syndrome. Hum Reprod 14 (1991) 1614-1618
45. Fuchs S., Philippe J., Germain S., Mathieu F., Jeunemaitre X., Corvol P., et al. Functionality of two new polymorphisms in the human renin gene enhancer region. J Hypertens 20 (2002) 2391-2398
46. Morgan T., Craven C., Lalouel J.M., and Ward K. Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. Am J Obstet Gynecol 180 (1999) 95-102
47. Alwan S., Polifka J.E., and Friedman J.M. Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Teratol 73 (2005) 123-130